Last update 26 Oct 2025

XTL6001

Overview

Basic Info

Drug Type
Recombinant polypeptide
Synonyms
XTL6001
Target
GCGR x GLP-1R x Mas receptor
Action
agonists
Mechanism
GCGR agonists(Glucagon receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists), Mas receptor agonists(Proto-oncogene Mas agonists)
Therapeutic Areas
Endocrinology and Metabolic DiseaseUrogenital Diseases
Active Indication
ObesityChronic Kidney DiseasesProteinuria
Inactive Indication
Metabolic Syndrome
Originator Organization
Shanghai Xitaili Biomedical Technology Co., Ltd.
Active Organization
Shanghai Xitaili Biomedical Technology Co., Ltd.Shaanxi Mycotech Pharmaceutical Technology Co., Ltd.Shaanxi Mycotech Pharmaceutical Technology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with XTL6001
NCT07205432
/ RecruitingPhase 1
A Randomized, Double-blind, Placebo-controlled Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Administration of XTL6001 Injection in Healthy and Obese Subjects
100 Clinical Results associated with XTL6001
Login to view more data
100 Translational Medicine associated with XTL6001
Login to view more data
100 Patents (Medical) associated with XTL6001
Login to view more data
100 Deals associated with XTL6001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ObesityPhase 1
China
Shanghai Xitaili Biomedical Technology Co., Ltd.
10 Jun 2025
Chronic Kidney DiseasesIND Approval
China
Shanghai Xitaili Biomedical Technology Co., Ltd.
01 Jul 2025
ProteinuriaIND Approval
China
Shanghai Xitaili Biomedical Technology Co., Ltd.
01 Jul 2025
Metabolic SyndromeIND Application
United States
Shaanxi Mycotech Pharmaceutical Technology Co., Ltd.Shaanxi Mycotech Pharmaceutical Technology Co., Ltd.
01 Dec 2024
Metabolic SyndromeIND Application
China
Shaanxi Mycotech Pharmaceutical Technology Co., Ltd.Shaanxi Mycotech Pharmaceutical Technology Co., Ltd.
01 Dec 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free